Truist downgraded Progyny (PGNY) to Hold from Buy with a price target of $19, down from $26. The firm says that while the company’s net member additions for 2025 essentially tracked broader investor expectations, the soft consumption trends flagged on its Q2 call worsened in Q3, resulting in another “miss and guide cut’ print. The limited visibility in the business model and lack of a satisfactory explanation from management on underperforming metrics mean that there is no clarity if trends have hit a trough, the analyst tells investors in a research note. Further, the recent loss of Progyny’s largest contract in Amazon is now going to weigh on the company’s growth trends in 2025, adds Truist.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY: